Literature DB >> 7436109

Pharmacokinetics of albendazole in sheep.

S E Marriner, J A Bogan.   

Abstract

The concentrations of albendazole and its two major metabolites, the sulfoxide and sulfone, were measured in plasma and in ruminal and abomasal fluid of three sheep (surgically prepared with permanent ruminal and abomasal cannulae) orally given albendazole as a suspension at a dose rate of 10 mg/kg. Albendazole was not detectable in plasma at any time in one sheep (detection limit, 0.02 micrograms/ml) and in the other sheep, only transiently detectable. Albendazole sulfoxide was detectable in plasma and in abomasal fluid at mean peak concentrations of 3.2 and 26.2 micrograms/ml, respectively, 20 hours after administration. It is probable that much of the anthelmintic activity of albendazole in sheep is due to the metabolically formed sulfoxide and sulfone.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7436109

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  19 in total

1.  Comparative performances of flubendazole and albendazole in cystic echinococcosis: ex vivo activity, plasma/cyst disposition, and efficacy in infected mice.

Authors:  Laura Ceballos; Celina Elissondo; Sergio Sánchez Bruni; Guillermo Denegri; Carlos Lanusse; Luis Alvarez
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  The efficacy and pharmacokinetics of long-term low-level intraruminal administration of triclabendazole in buffalo with induced fasciolosis.

Authors:  P K Sanyal; S C Gupta
Journal:  Vet Res Commun       Date:  1996       Impact factor: 2.459

3.  Pharmacokinetics of ricobendazole after its intravenous, intraruminal and subcutaneous administration in sheep.

Authors:  E A Formentini; N Mestorino; J O Errecalde
Journal:  Vet Res Commun       Date:  2005-10       Impact factor: 2.459

4.  Some aspects of the teratogenicity of veterinary drugs.

Authors:  P Delatour
Journal:  Vet Res Commun       Date:  1983-12       Impact factor: 2.459

5.  Albendazole in hydatid disease.

Authors:  D L Morris; P W Dykes; B Dickson; S E Marriner; J A Bogan; F G Burrows
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-08

6.  The pharmacokinetics of fenbendazole and oxfendazole in cattle.

Authors:  A J Ngomuo; S E Marriner; J A Bogan
Journal:  Vet Res Commun       Date:  1984-08       Impact factor: 2.459

7.  Oxfendazole treatment for cystic hydatid disease in naturally infected animals.

Authors:  R E Blanton; T M Wachira; E E Zeyhle; E M Njoroge; J K Magambo; P M Schantz
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

8.  Albendazole in environment: faecal concentrations in lambs and impact on lower development stages of helminths and seed germination.

Authors:  Lukáš Prchal; Radka Podlipná; Jiří Lamka; Tereza Dědková; Lenka Skálová; Ivan Vokřál; Lenka Lecová; Tomáš Vaněk; Barbora Szotáková
Journal:  Environ Sci Pollut Res Int       Date:  2016-03-21       Impact factor: 4.223

Review 9.  Pharmacokinetic optimisation of the treatment of neurocysticercosis.

Authors:  J Sotelo; H Jung
Journal:  Clin Pharmacokinet       Date:  1998-06       Impact factor: 6.447

10.  Pharmacokinetics of albendazole in man.

Authors:  S E Marriner; D L Morris; B Dickson; J A Bogan
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.